Chapel Hill, NC, United States of America

Dirk P Dittmer

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Oklahoma. Active years: 2010.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk P Dittmer: Innovator in RNA Virus Vaccines

Introduction

Dirk P Dittmer is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of virology, particularly in the development of vaccines against RNA viruses. His innovative work has the potential to impact public health positively.

Latest Patents

Dirk P Dittmer holds a patent for "RNA virus vaccines and methods." This invention focuses on a vaccine and method of vaccination against RNA viruses, including those in the family Flaviviridae. Notable examples include the West Nile Virus, Yellow fever virus, Dengue fever virus, Hepatitis C virus, Pestiviruses, Bovine viral diarrhea virus, and Classical Swine fever virus. The vaccine comprises the RNA virus or immunogenic portions that have been treated with a phenothiazine dye and visible light to render them non-pathogenic. Additionally, the invention includes novel strains of West Nile Virus for use in vaccine production.

Career Highlights

Dirk P Dittmer is affiliated with the University of Oklahoma, where he continues to advance research in virology and vaccine development. His work has garnered attention for its innovative approach to combating RNA viruses.

Collaborations

Dirk has collaborated with Robert A Floyd, contributing to the advancement of research in their field. Their partnership has led to significant developments in vaccine technology.

Conclusion

Dirk P Dittmer's contributions to RNA virus vaccines exemplify the importance of innovation in public health. His work not only addresses current health challenges but also paves the way for future advancements in vaccine technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…